PAK Inhibitor FRAX486 Decreases the Metastatic Potential of Triple-Negative Breast Cancer Cells by Blocking Autophagy

Researchers reported that FRAX486, a potent P21-activated kinase 2 (PAK2) inhibitor, facilitated TNBC suppression both in vitro and in vivo by blocking autophagy.